Application and Development of Cell Membrane Functionalized Biomimetic Nanoparticles in the Treatment of Acute Ischemic Stroke
Open Access
- 5 August 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8539
Abstract
Ischemic stroke is a serious neurological disease involving multiple complex physiological processes, including vascular obstruction, brain tissue ischemia, impaired energy metabolism, cell death, impaired ion pump function, and inflammatory response. In recent years, there has been significant interest in cell membrane-functionalized biomimetic nanoparticles as a novel therapeutic approach. This review comprehensively explores the mechanisms and importance of using these nanoparticles to treat acute ischemic stroke with a special emphasis on their potential for actively targeting therapies through cell membranes. We provide an overview of the pathophysiology of ischemic stroke and present advances in the study of biomimetic nanoparticles, emphasizing their potential for drug delivery and precision-targeted therapy. This paper focuses on bio-nanoparticles encapsulated in bionic cell membranes to target ischemic stroke treatment. It highlights the mechanism of action and research progress regarding different types of cell membrane-functionalized bi-onic nanoparticles such as erythrocytes, neutrophils, platelets, exosomes, macrophages, and neural stem cells in treating ischemic stroke while emphasizing their potential to improve brain tissue’s ischemic state and attenuate neurological damage and dysfunction. Through an in-depth exploration of the potential benefits provided by cell membrane-functionalized biomimetic nanoparticles to improve brain tissue’s ischemic state while reducing neurological injury and dysfunction, this study also provides comprehensive research on neural stem cells’ potential along with that of cell membrane-functionalized biomimetic nanoparticles to ameliorate neurological injury and dysfunction. However, it is undeniable that there are still some challenges and limitations in terms of biocompatibility, safety, and practical applications for clinical translation.Keywords
Funding Information
- Natural Science Foundation of Xiamen Medical College (K2021-03, 2021J01344, 2023ZQNZD019, 2021J01344, 3502Z20224ZD1301, K2023-10, 202312631017, 2023B02030, 2023B02030-1)
- Fujian Province Science and Technology Plant Project (K2021-03, 2021J01344, 2023ZQNZD019, 2021J01344, 3502Z20224ZD1301, K2023-10, 202312631017, 2023B02030, 2023B02030-1)
- Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China (K2021-03, 2021J01344, 2023ZQNZD019, 2021J01344, 3502Z20224ZD1301, K2023-10, 202312631017, 2023B02030, 2023B02030-1)
- Fujian Province Science and Technology Plant Project (Younth) (K2021-03, 2021J01344, 2023ZQNZD019, 2021J01344, 3502Z20224ZD1301, K2023-10, 202312631017, 2023B02030, 2023B02030-1)
- xiamen medical and health guidance project (K2021-03, 2021J01344, 2023ZQNZD019, 2021J01344, 3502Z20224ZD1301, K2023-10, 202312631017, 2023B02030, 2023B02030-1)
- Natural Science Foundation of Xiamen Medical College (K2021-03, 2021J01344, 2023ZQNZD019, 2021J01344, 3502Z20224ZD1301, K2023-10, 202312631017, 2023B02030, 2023B02030-1)
- Fujian Province University Student Innovation Plan Training Projec (K2021-03, 2021J01344, 2023ZQNZD019, 2021J01344, 3502Z20224ZD1301, K2023-10, 202312631017, 2023B02030, 2023B02030-1)
- the Key Research and Development Program in the Xinjiang Uygur Autonomous Region (K2021-03, 2021J01344, 2023ZQNZD019, 2021J01344, 3502Z20224ZD1301, K2023-10, 202312631017, 2023B02030, 2023B02030-1)
This publication has 78 references indexed in Scilit:
- Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke TherapyAdvanced Materials, 2024
- Macrophage Membrane‐Modified MoS2 Quantum Dots as a Nanodrug for Combined Multi‐Targeting of Alzheimer's DiseaseAdvanced Healthcare Materials, 2023
- A Homing Peptide Modified Neutrophil Membrane Biomimetic Nanoparticles in Response to ROS/inflammatory Microenvironment for Precise Targeting Treatment of Ischemic StrokeAdvanced Functional Materials, 2023
- Neuroprotective Treatments for Ischemic Stroke: Opportunities for NanotechnologyAdvanced Functional Materials, 2022
- Annexin V‐Modified Platelet‐Biomimetic Nanomedicine for Targeted Therapy of Acute Ischemic StrokeAdvanced Healthcare Materials, 2022
- What Is Acute Ischemic Stroke?JAMA, 2022
- Cell Membrane Vesicles with Enriched CXCR4 Display Enhances Their Targeted Delivery as Drug Carriers to Inflammatory SitesAdvanced Science, 2021
- Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to CarrierAdvanced Science, 2021
- Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis ModelsAdvanced Materials, 2019
- Engineering Cell Membrane‐Based Nanotherapeutics to Target InflammationAdvanced Science, 2019